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OBJECTIVES 
Patients with peritoneal carcinomatosis suffer from a widespread metastatic growth of tumor nodules in 
the peritoneal cavity. Although Intraperitoneal (IP) chemotherapy allows for higher intratumor 
concentrations of the cytotoxic agent compared to intravenous administration, actual application of IP 
chemotherapy is limited due to poor drug penetration (typically a few millimeters) in the tumor tissue. It 
is thus essential to better understand the drug transport during IP chemotherapy.  
METHODS 
A  3D  computational fluid dynamics  model of a tumor nodule with necrotic core was created in Comsol® 
(COMSOL, Inc., Burlington, USA) describing  the drug transport occurring during IP chemotherapy, 
including convective/diffusive/reactive drug transport in two tumor geometries (a spherical baseline 
model with radius rsphere,large=1 cm/rsphere,small=2 mm and rnecrotic,large=5 mm/rnecrotic,large=1 mm). To assess the 
efficiency of drug administration, a penetration depth (PD) was defined as the percentage of the total 
radius in which the drug concentration resulted to be over 6.6E-3 mol/m3. These baseline models were 
subsequently adapted to evaluate the effect of therapy-related parameters (different drugs, vascular 
properties etc.) on drug penetration. 
RESULTS 
A large differences in PD (PD; % of total radius) were found in the baseline cases for the two different 
scales (PDsphere,large= 4.04%; PDsphere,small=20.82%).Vascular normalization therapy yielded different 
outcomes (ΔPDsphere,large+2.95%; ΔPDsphere,small +17.95%). Both cases showed less penetration when 
paclitaxel was used as opposed to cisplatin. This effect was more pronounced in the smaller geometry 
(ΔPDsphere,large =-1.91%; ΔPDsphere,small =-10.25%). 
CONCLUSIONS 
The model is able to predict drug penetration depth for different sets of IP chemotherapy-related 
parameters, which may lead to optimization of drug transport during IP chemotherapy.  
